(Q43548625)

English

Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study

scientific article published in March 2001

Statements

Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study (English)
1 March 2001
500-506

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit